BlackRock, Inc. Increases Stake in Elanco Animal Health Inc

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Elanco Animal Health Inc. As of September 30, 2025, BlackRock beneficially owns 44,021,766 shares of Elanco's common stock, representing 8.9% of the total outstanding shares. This marks a significant increase from previous holdings, with a 77.26% rise in both the number of shares and their value. The filing indicates that BlackRock acquired these shares in the ordinary course of business and not with the intent to influence control of Elanco. The shares are held by various business units of BlackRock, and no single entity owns more than 5% of the total outstanding shares. The filing was signed by Spencer Fleming, Managing Director at BlackRock, on October 17, 2025.